The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Stafford, Phillip ^a   Abdelwahab, Mohammed G ^b   Kim, Do Young ^b   Preul, Mark C ^b   Rho, Jong M ^b   Scheck, Adrienne C ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; KETONE; REACTIVE OXYGEN METABOLITE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA; GROWTH INHIBITION; KAPLAN MEIER METHOD; KETOGENIC DIET; MOUSE; NONHUMAN; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR CELL; TUMOR GROWTH;

ANIMALIA;

EID: 77956465178     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-74     Document Type: Article

References (59)

1. Phase II trial of temozolomide in children with recurrent high-grade glioma. A Ruggiero G Cefalo ML Garre M Massimino C Colosimo G Attina, et al. J Neurooncol 2005 1 6
2. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. TN Seyfried TM Sanderson MM El-Abbadi R McGowan P Mukherjee, Br J Cancer 2003 89 1375 1382 10.1038/sj.bjc.6601269 14520474
3. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. LC Nebeling F Miraldi SB Shurin E Lerner, J Am Coll Nutr 1995 14 202 208 7790697
4. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. LC Nebeling E Lerner, J Am Diet Assoc 1995 95 693 697 10.1016/S0002-8223(95)00189-1 7759747
5. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. G Zuccoli N Marcello A Pisanello F Servadei S Vaccaro P Mukherjee, et al. Nutrition and Metabolism 2010 7 33 53 10.1186/1743-7075-7-33 20412570
6. Neuroprotective and disease-modifying effects of the ketogenic diet. M Gasior MA Rogawski AL Hartman, Behav Pharmacol 2006 17 431 439 10.1097/00008877-200609000-00009 16940764
7. The ketogenic diet and epilepsy. DY Kim JM Rho, Curr Opin Clin Nutr Metab Care 2008 11 113 120 10.1097/MCO.0b013e3282f44c06 18301085
8. Reactive oxygen species: a breath of life or death? JP Fruehauf FL Meyskens Jr, Clin Cancer Res 2007 13 789 794 10.1158/1078-0432.CCR-06-2082 17289868
9. Reactive oxygen species-dependent signaling regulates cancer. F Weinberg NS Chandel, Cell Mol Life Sci 2009 66 3663 3673 10.1007/s00018-009-0099-y 19629388
10. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. EW Newcomb S Demaria Y Lukyanov Y Shao T Schnee N Kawashima, et al. Clin Cancer Res 2006 12 4730 4737 10.1158/1078-0432.CCR-06-0593 16899624
11. Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model. E Jouanneau D Poujol S Gulia M Le JY Blay MF Belin, et al. Cancer Immunol Immunother 2006 55 254 267 10.1007/s00262-005-0040-7 16133115
12. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. JM Rho DW Kim CA Robbins GD Anderson PA Schwartzkroin, Epilepsy Res 1999 37 233 240 10.1016/S0920-1211(99)00068-6 10584973
13. Lack of long-term histopathologic changes in brain and skeletal muscle of mice treated with a ketogenic diet. JM Rho HB Sarnat PG Sullivan CA Robbins DW Kim, J Child Neurol 2004 19 555 557 15526964
14. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. M Maalouf PG Sullivan L Davis DY Kim JM Rho, Neuroscience 2007 145 256 264 10.1016/j.neuroscience.2006.11.065 17240074
15. Three methods for optimization of cross-laboratory and cross-platform microarray expression data. P Stafford M Brun, Nucl Acids Res 2007 35 72 10.1093/nar/gkl1133 17478523
16. Flavopiridol inhibits the growth of GL261 gliomas in vivo: implications for malignant glioma therapy. EW Newcomb C Tamasdan Y Entzminger E Arena T Schnee M Kim, et al. Cell Cycle 2004 3 230 234 14712094
17. Radiation Sensitivity of GL261 Murine Glioma Model and Enhanced Radiation Response by Flavopiridol. EW Newcomb SC Lymberis Y Lukyanov Y Shao T Schnee M Devitt, et al. Cell Cycle 2006 5 93 99 16319534
18. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. T Szatmari K Lumniczky S Desaknai S Trajcevski EJ Hidvegi H Hamada, et al. Cancer Sci 2006 97 546 553 10.1111/j.1349-7006.2006.00208.x 16734735
19. A syngeneic mouse glioma model for study of glioblastoma therapy. RB Pyles CL Chalk MG Balko MA Miller CA Dyer, et al. J Neuropath Exp Neurol 1999 58 54 60 10.1097/00005072-199901000-00007 10068314
20. Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas. KM Laughlin D Luo C Liu G Shaw KH Warrington J Qiu, et al. Pathol Oncol Res 2009 15 12253 12267 10.1007/s12253-008-9147-4
21. Targeting energy metabolism in brain cancer: review and hypothesis. TN Seyfried P Mukherjee, Nutrition and Metabolism 2005 2 30 38 10.1186/1743-7075-2- 30 16242042
22. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. LB Mahoney CA Denny TN Seyfried, Lipids Health Dis 2006 5 13 10.1186/1476-511X-5-13 16709251
23. Antiepileptic popular ketogenic diet: emerging twists in an ancient story. J Vamecq L Vallee F Lesage P Gressens JP Stables, Prog Neurobiol 2005 75 1 28 10.1016/j.pneurobio.2004.11.003 15713528
24. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. A Dekundy M Pietraszek D Schaefer MA Cenci W Danysz, Brain Res Bull 2006 69 318 326 10.1016/j.brainresbull.2005.12. 009 16564428
25. Omega-3 fatty acids, energy substrates, and brain function during aging. E Freemantle M Vandal J Tremblay-Mercier S Tremblay JC Blachere ME Begin, et al. Prostaglandins Leukot Essent Fatty Acids 2006 75 213 220 10.1016/j.plefa.2006. 05.011 16829066
26. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. MG Jabre BP Bejjani, Neurology 2006 66 617 10.1212/01.wnl.0000216108.57529.b1 16505339
27. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. Y Liao S Takashima H Zhao Y Asano Y Shintani T Minamino, et al. Cardiovasc Res 2006 70 107 116 10.1016/j.cardiores.2006.01.021 16510136
28. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. ML Prins LS Fujima DA Hovda, J Neurosci Res 2005 82 413 420 10.1002/jnr.20633 16180224
29. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. Z Zhao DJ Lange A Voustianiouk D MacGrogan L Ho J Suh, et al. BMC Neurosci 2006 7 29 10.1186/1471-2202-7-29 16584562
30. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. P Mukherjee MM El-Abbadi JL Kasperzyk MK Ranes TN Seyfried, Br J Cancer 2002 86 1615 1621 10.1038/sj.bjc.6600298 12085212
31. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. P Mukherjee LE Abate TN Seyfried, Clin Cancer Res 2004 10 5622 5629 10.1158/1078-0432.CCR-04-0308 15328205
32. Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. P Mukherjee TJ Mulrooney J Marsh D Blair TC Chiles TN Seyfried, Mol Cancer 2008 7 37 10.1186/1476-4598-7-37 18474106
33. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. H Ito S Daido T Kanzawa S Kondo Y Kondo, Int J Oncol 2005 26 1401 1410 15809734
34. Glucose metabolism and proliferation in glia: role of astrocytic gap junctions. A Tabernero JM Medina C Giaume, J Neurochem 2006 99 1049 1061 10.1111/j.1471-4159.2006.04088.x 16899068
35. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. J Marsh P Mukherjee TN Seyfried, Nutr Metab (Lond) 2008 5 33 10.1186/1743-7075-5-33 19032781
36. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. HS Noh HP Lee DW Kim SS Kang GJ Cho JM Rho, et al. Brain Res Mol Brain Res 2004 129 80 87 15469884
37. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. KJ Bough J Wetherington B Hassel JF Pare JW Gawryluk JG Greene, et al. Ann Neurol 2006 60 223 235 10.1002/ana.20899 16807920
38. A high-fat, ketogenic diet induces a unique metabolic state in mice. AR Kennedy P Pissios H Otu B Xue K Asakura N Furukawa, et al. Am J Physiol Endocrinol Metab 2007 292 1724 E1739 10.1152/ajpendo.00717.2006 17299079
39. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. ES Muise B Azzolina DW Kuo M El-Sherbeini Y Tan X Yuan, et al. Mol Pharmacol 2008 74 403 412 10.1124/mol.108.044826 18467542
40. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. E Erol LS Kumar GW Cline GI Shulman DP Kelly B Binas, FASEB J 2004 18 347 349 14656998
41. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. PG Sullivan NA Rippy K Dorenbos RC Concepcion AK Agarwal JM Rho, Ann Neurol 2004 55 576 580 10.1002/ana.20062 15048898
42. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. N Aykin-Burns IM Ahmad Y Zhu LW Oberley DR Spitz, Biochem J 2009 418 29 37 10.1042/BJ20081258 18937644
43. Adaptation to oxidative stress, chemoresistance, and cell survival. M Landriscina F Maddalena G Laudiero F Esposito, Antioxid Redox Signal 2009 11 2701 2716 10.1089/ars.2009.2692 19778285
44. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. GL Semenza, Semin Cancer Biol 2009 19 12 16 10.1016/j.semcancer.2008.11.009 19114105
45. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? D Trachootham J Alexandre P Huang, Nat Rev Drug Discov 2009 8 579 591 10.1038/nrd2803 19478820
46. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Y Chen E McMillan-Ward J Kong SJ Israels SB Gibson, Cell Death Differ 2008 15 171 182 10.1038/sj.cdd.4402233 17917680
47. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. N Pore Z Jiang HK Shu E Bernhard GD Kao A Maity, Mol Cancer Res 2006 4 471 479 10.1158/1541-7786.MCR-05-0234 16849522
48. Cyclooxygenase-2 inhibitors in glioma therapy. P Giglio V Levin, Am J Ther 2004 11 141 143 10.1097/00045391-200403000-00009 14999366
49. The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas. S Mattila H Tuominen J Koivukangas F Stenback, Neuropathology 2009 29 156 165 10.1111/j.1440-1789.2008.00963.x 19347995
50. Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy. AH Schonthal, Neurosurg Focus 2006 20 21 10.3171/foc.2006.20.4.14 16709027
51. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. C Sobolewski C Cerella M Dicato L Ghibelli M Diederich, Int J Cell Biol 2010 215158 Epub@2010 Mar 17 20339581
52. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model. CK Kim YA Joe SK Lee EK Kim E O HK Kim, et al. Cancer Lett 2010 288 251 260 10.1016/j.canlet.2009.07.008 19664879
53. Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. A Utomo X Jiang S Furuta J Yun DS Levin YC Wang, et al. J Biol Chem 2004 279 43522 43529 10.1074/jbc.M407141200 15294905
54. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. A Okado-Matsumoto A Matsumoto J Fujii N Taniguchi, Journal of Biochemistry 2000 127 493 501 10731722
55. Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. DR Ziegler LC Ribeiro M Hagenn IR Siqueira E Araujo IL Torres, et al. Neurochem Res 2003 28 1793 1797 10.1023/A:1026107405399 14649719
56. Cytoglobin up-regulated by hydrogen peroxide plays a protective role in oxidative stress. D Li XQ Chen WJ Li YH Yang JZ Wang AC Yu, Neurochem Res 2007 32 1375 1380 10.1007/s11064-007-9317-x 17476593
57. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. N Shivapurkar V Stastny N Okumura L Girard Y Xie C Prinsen, et al. Cancer Res 2008 68 7448 7456 10.1158/0008-5472.CAN-08-0565 18794132
58. NOXO1, Regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. G Cheng JD Lambeth, J Biol Chem 2004 279 4737 4742 10.1074/jbc.M305968200 14617635
59. The JmjC domain histone demethylase Ndy1 regulates redox homeostasis and protects cells from oxidative stress. C Polytarchou R Pfau M Hatziapostolou PN Tsichlis, Molecular and Cellular Biology 2008 28 7451 7464 10.1128/MCB.00688-08 18838535